Pooled analysis of tiotropium Respimat® pharmacokinetics in cystic fibrosis-Reference-Cited by-同舟云学术

Pooled analysis of tiotropium Respimat® pharmacokinetics in cystic fibrosis

Published:2014-12 Issue:2 Volume:29 Page:217-223
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Sharma Ashish,Geller David E.,Moroni-Zentgraf Petra,Kattenbeck Sabine,Schmid Marion,Boland Katja,Rapp Barbara,Konstan Michael W.,Ratjen Felix,Elborn J. Stuart,Koker Paul

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference31 articles.

1. Reversible airway obstruction in cystic fibrosis;Ormerod;Thorax,1980

2. Airways reactivity in patients with CF;Weinberger;Clin Rev Allergy Immunol,2002

3. Cystic fibrosis;Davis;Am J Respir Crit Care Med,1996

4. Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes;Sawicki;J Cyst Fibros,2013

5. Trends in the use of routine therapies in cystic fibrosis: 1995-2005;Konstan;Pediatr Pulmonol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-acting inhaled bronchodilators for cystic fibrosis;Cochrane Database of Systematic Reviews;2022-06-24

2. Pharmacokinetics of tiotropium in asthmatic children aged 6-11 years support its safety profile;Pediatric Allergy and Immunology;2018-09-03

3. Long-acting inhaled bronchodilators for cystic fibrosis;Cochrane Database of Systematic Reviews;2017-12-18

4. Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials;Pulmonary Pharmacology & Therapeutics;2017-02

5. Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis;PLOS ONE;2016-06-28